77D Stock Overview

An investment holding company, researches and develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China. More details

77D fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	0/6
Financial Health	5/6
Dividends	1/6

Rewards

Trading at 28% below our estimate of its fair value

Earnings are forecast to grow 69.59% per year

Analysts in good agreement that stock price will rise by 35.8%

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

Profit margins (2.5%) are lower than last year (13.1%)

My Notes

Capture your thoughts, links and company narrative

Angelalign Technology Inc. Competitors

Eckert & Ziegler

XTRA:EUZ

€1.2b

Drägerwerk KGaA

XTRA:DRW3

€987.9m

Stratec

XTRA:SBS

€434.0m

Carl Zeiss Meditec

XTRA:AFX

€5.0b

Price History & Performance

Summary of share price highs, lows and changes for Angelalign Technology
Historical stock prices
Current Share Price	HK$7.38
52 Week High	HK$7.52
52 Week Low	HK$6.44
Beta	1.15
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	12.67%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	77D	DE Medical Equipment	DE Market
7D	11.4%	2.0%	-0.02%
1Y	n/a	-2.7%	15.1%

Return vs Industry: Insufficient data to determine how 77D performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how 77D performed against the German Market.

Price Volatility

Is 77D's price volatile compared to industry and market?
77D volatility
77D Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	6.4%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.3%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 77D's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 77D's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2003	3,547	Jiezhang Hu	www.angelalign.com

Angelalign Technology Inc., an investment holding company, researches and develops, designs, manufactures, and markets clear aligner treatment solutions in the People’s Republic of China. The company’s products include Angel Aligner Pro, a custom made removable clear orthodontic aligners that move the patient’s teeth into the proper position over time. It also provides orthodontics and cosmetic dentistry services, and other dental services through its dental clinics, as well as sells intraoral scanners.

Angelalign Technology Inc. Fundamentals Summary

How do Angelalign Technology's earnings and revenue compare to its market cap?
77D fundamental statistics
Market cap	€1.28b
Earnings (TTM)	€5.80m
Revenue (TTM)	€228.63m

221.0x

P/E Ratio

5.6x

P/S Ratio

Is 77D overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
77D income statement (TTM)
Revenue	CN¥1.72b
Cost of Revenue	CN¥628.28m
Gross Profit	CN¥1.09b
Other Expenses	CN¥1.05b
Earnings	CN¥43.65m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.26
Gross Margin	63.50%
Net Profit Margin	2.54%
Debt/Equity Ratio	9.9%

How did 77D perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

n/a

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 11:32
End of Day Share Price	2025/02/07 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Angelalign Technology Inc. is covered by 17 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Tingting Li	BOCI Research Ltd.
Bo Li	BofA Global Research
Yanyin Zhu	China International Capital Corporation Limited